抗寄生虫药物发现中的天然产品:进步,机遇和挑战
Xiaofei Shang1,2,3, Lixia Dai1, Xinyuan Cao4
1Key Laboratory of Veterinary Pharmaceutical Development of Ministry of Agriculture, Key Laboratory of New Animal Drug Project, Gansu Province, Lanzhou Institute of Husbandry and Pharmaceutical Sciences, Chinese Academy of Agricultural Sciences, Lanzhou, China. yangxiaorong01@caas.cn.
Natural product reports
|June 12, 2025
概括
尽管存在挑战,但天然产品为开发新的抗寄生虫药物提供了有希望的来源. 先进的技术增强了这些化合物的发现和优化,用于人类和兽医健康.
科学领域:
- * 药理学与药物发现
- * 传染病和热带医学
- * * 自然产品化学 自然产品化学
背景情况:
- *寄生虫感染影响全球数百万人,造成严重的发病率,死亡率和社会经济负担,特别是在发展中国家.
- * 传统医学历史上一直利用天然产品 (NP) 来治疗寄生病,其中一些衍生品已达到临床应用.
- *尽管有现有的治疗方法,但由于耐药性和疾病流行率,对新型抗寄生虫剂的需求仍然至关重要.
研究的目的:
- * 审查从自然资源中开发抗寄生虫药物的战略.
- * 描述寄生病的流行病学,病原体和当前治疗方法.
- *强调有前途的天然产品及其衍生品,包括机制和优化.
主要方法:
- * 对具有抗寄生虫活性的天然产品及其衍生物进行了全面的文献综述.
- * 药物开发过程的分析,包括技术进步和挑战.
- * 对基于天然产品的抗寄生虫药物发现研究趋势的前性分析.
主要成果:
- *许多天然产品及其衍生品显示出显著的抗寄生素潜力,例如氨酸,氨酸和氨酸,证明了临床成功.
- *革命性的技术正在加速从自然来源识别和优化新型化合物.
- *自然产品药物开发的挑战包括高消耗率,供应链问题和知识产权限制.
结论:
- *自然产品是发现新型抗寄生虫剂的重要和多样化的储备.
- * 尽管存在发展障碍,但天然产品衍生药物在对抗寄生虫疾病方面已被证明具有治疗意义.
- * 综合先进技术的持续研究将增强天然产品对人类和兽医健康的贡献.
相关概念视频
Drug Discovery: Overview
7.6K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.6K
Structure-Activity Relationships and Drug Design
676
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
676
Preclinical Development: Overview
4.3K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.3K
Effects of Chemicals: Overview
1.2K
Drugs, encompassing various chemical compounds from natural sources, lab synthesis, or genetic engineering, elicit different biological responses in living organisms. Some of these responses are desirable or therapeutic, while others are undesirable. The primary goal of administering a drug is to achieve a therapeutic effect, that is, to address a specific disease or health condition. Any concurrent effects outside of this therapeutic outcome are considered undesirable. These undesirable...
1.2K
Combined Effects of Drugs: Synergism
3.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.8K


